Cited by 441Liver Disease Diagnosis and TreatmentMitochondrial Function and PathologyDiet, Metabolism, and Disease

The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.

NASH: a mitochondrial disease

Pessayre, Dominique, Fromenty, Bernard·2005·Journal of Hepatology

DOI 10.1016/j.jhep.2005.03.004

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2005.03.004

Cites

124 of 124 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Leptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405
Obesity as a medical problem
Kopelman, P. G. (2000) · Nature · doi:10.1038/35007508 · Cited by 4,795
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes
Özcan, U., Cao, Q., Yilmaz, E., Lee, A.-H., Iwakoshi, N. N., Özdelen, E., Tuncman, G., Görgün, C., Glimcher, L. H., & Hotamisligil, G. S. (2004) · Science · doi:10.1126/science.1103160 · Cited by 3,844
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359
Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.
Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., & Henson, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1112 · Cited by 3,166 · cited 2×
“[114] Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM.”
Background
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193
Mitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107

Show all 123 references

Sorted by citations

Items 101–200 of 440

N-Acetylcysteine Attenuates Progression of Liver Pathology in a Rat Model of Nonalcoholic Steatohepatitis3
Baumgardner, J. N., Shankar, K., Hennings, L. J., Albano, E., Badger, T. M., & Ronis, M. J. J. (2008) · Journal of Nutrition · doi:10.1093/jn/138.10.1872 · Cited by 100
Oral Formulation of Angiotensin-(1–7) Improves Lipid Metabolism and Prevents High-Fat Diet–Induced Hepatic Steatosis and Inflammation in Mice
Feltenberger, J. D., Andrade, J. M. O., Paraíso, A. F., Barros, L. O., Filho, A. B. M., Sinisterra, R. D., Sousa, F. B. D., Guimarães, A. L. S., de Paula, A. M. B., Campagnole‐Santos, M. J., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00919 · Cited by 99
Three-dimensional ultrastructure of giant mitochondria in human non-alcoholic fatty liver disease
Shami, G. J., Cheng, D., Verhaegh, P. L. M., Koek, G. H., Wisse, E., & Braet, F. (2021) · Scientific Reports · doi:10.1038/s41598-021-82884-z · Cited by 97
Ethanol increases mitochondrial cytochrome P450 2E1 in mouse liver and rat hepatocytes
Robin, M., Sauvage, I., Grandperret, T., Descatoire, V., Pessayre, D., & Fromenty, B. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.11.029 · Cited by 94
Self-citation
Mitochondrial Dysfunction in the Transition from NASH to HCC
Léveillé, M., & Estall, J. L. (2019) · Metabolites · doi:10.3390/metabo9100233 · Cited by 94
Carbon monoxide releasing molecule-A1 improves nonalcoholic steatohepatitis via Nrf2 activation mediated improvement in oxidative stress and mitochondrial function
Upadhyay, K. K., Jadeja, R. N., Vyas, H., Pandya, B. A., Joshi, A., Vohra, A., Thounaojam, M. C., Martin, P. M., Bartoli, M., & Devkar, R. V. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101314 · Cited by 91
From the origin of NASH to the future of metabolic fatty liver disease
Geier, A., Tiniakos, D., Denk, H., & Trauner, M. (2021) · Gut · doi:10.1136/gutjnl-2020-323202 · Cited by 80
Punicalagin attenuates palmitate‐induced lipotoxicity in HepG2 cells by activating the Keap1‐Nrf2 antioxidant defense system
Yan, C., Sun, W., Wang, X., Long, J., Liu, X., Feng, Z., & Liu, J. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500490 · Cited by 90
Effect of dietary lipid level on growth, lipid metabolism and health status of the Pacific white shrimpLitopenaeus vannameiat two salinities
Xu, C., Li, E., Liu, Y., Wang, S., Wang, X., Chen, K., Qin, J. G., & Chen, L. (2017) · Aquaculture Nutrition · doi:10.1111/anu.12548 · Cited by 91
It Is High Time Physicians Thought of Natural Products for Alleviating NAFLD. Is There Sufficient Evidence to Use Them?
Tarantino, G., Balsano, C., Santini, S. J., Brienza, G., Clemente, I., Cosimini, B., & Sinatti, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413424 · Cited by 90
Does oxidative stress participate in the development of hepatocellular carcinoma?
Sasaki, Y. (2007) · Journal of Gastroenterology · doi:10.1007/s00535-006-1982-z · Cited by 89
Mitochondrial oxidative injury: a key player in nonalcoholic fatty liver disease
Dornas, W., & Schuppan, D. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00121.2020 · Cited by 89
Mitochondrial dysfunction in nonalcoholic steatohepatitis
Serviddio, G., Bellanti, F., Vendemiale, G., & Altomare, E. (2011) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.11 · Cited by 87
Lipid in the livers of adolescents with nonalcoholic steatohepatitis: combined effects of pathways on steatosis
Zhu, L., Baker, S. S., Liu, W., Tao, M., Patel, R. A., Nowak, N. J., & Baker, R. D. (2010) · Metabolism · doi:10.1016/j.metabol.2010.10.003 · Cited by 88
Mitochondrial GSH determines the toxic or therapeutic potential of superoxide scavenging in steatohepatitis
Montfort, C. V., Matias, N., Fernandez, A., Fucho, R., de la Rosa, L. C., Martinez-Chantar, M. L., Mato, J. M., Machida, K., Tsukamoto, H., Murphy, M. P., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.05.024 · Cited by 83
Busting the myth of methotrexate chronic hepatotoxicity
Martino, V. D., Weil, D., Verhoeven, F., Aubin, F., Avouac, J., Vuitton, L., Lioté, F., Thévenot, T., & Wendling, D. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00883-4 · Cited by 83
The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease
Malik, R., Chang, M., Bhaskar, K. R., Nasser, I. A., Curry, M. P., Schuppan, D., Byrnes, V., & Afdhal, N. H. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05731.x · Cited by 83
Diet-Sensitive Sources of Reactive Oxygen Species in Liver Mitochondria: Role of Very Long Chain Acyl-CoA Dehydrogenases
Cardoso, A. R., Kakimoto, P. A., & Kowaltowski, A. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077088 · Cited by 86
Hepatic miR-144 Drives Fumarase Activity Preventing NRF2 Activation During Obesity
Azzimato, V., Chen, P., Barreby, E., Morgantini, C., Levi, L., Vankova, A., Jager, J., Sulen, A., Diotallevi, M., Shen, J. X., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.08.030 · Cited by 81
The role of angiotensin II in nonalcoholic steatohepatitis
Morris, E. M., Fletcher, J. A., Thyfault, J. P., & Rector, R. S. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.04.013 · Cited by 81
Catalase and nonalcoholic fatty liver disease
Shin, S., Cho, H.-W., Song, S.-E., & Song, D. (2018) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-018-2195-z · Cited by 81
The roles of FGF21 and GDF15 in mediating the mitochondrial integrated stress response
Jena, J., García-Peña, L. M., & Pereira, R. O. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1264530 · Cited by 78
A subset of dysregulated metabolic and survival genes is associated with severity of hepatic steatosis in obese Zucker rats
Buqué, X., Martínez, M. J., Cano, A., Miquilena-Colina, M. E., García‐Monzón, C., Aspichueta, P., & Ochoa, B. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m001966 · Cited by 78
Intramitochondrial crystalline inclusions in nonalcoholic steatohepatitis†
Caldwell, S. H., de Freitas, L. A. R., Park, S. H., Moreno, M. L. V., Redick, J. A., Davis, C. A., Sisson, B. J., Patrie, J. T., Cotrim, H. P., Argo, C. K., et al. (2009) · Hepatology · doi:10.1002/hep.22851 · Cited by 75
Obesity and the liver: nonalcoholic fatty liver disease
Koppe, S. (2014) · Translational research · doi:10.1016/j.trsl.2014.06.008 · Cited by 74
Reversibility of fibrosis, inflammation, and endoplasmic reticulum stress in the liver of rats fed a methionine–choline-deficient diet
Mu, Y., Ogawa, T., & Kawada, N. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.123 · Cited by 73
Geranylgeranyl diphosphate synthase (GGPPS) regulates non‐alcoholic fatty liver disease (NAFLD)–fibrosis progression by determining hepatic glucose/fatty acid preference under high‐fat diet conditions
Liu, J., Jiang, S., Zhao, Y., Sun, Q., Zhang, J., Shen, D., Wu, J., Shen, N., Fu, X., Sun, X., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5131 · Cited by 72
Mitochondria and Redox Signaling in Steatohepatitis
Morris, E. M., Rector, R. S., Thyfault, J. P., & Ibdah, J. A. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3795 · Cited by 71
Insulin Resistance and Other Metabolic Risk Factors in the Pathogenesis of Hepatocellular Carcinoma
Siddique, A., & Kowdley, K. V. (2011) · Clinics in Liver Disease · doi:10.1016/j.cld.2011.03.007 · Cited by 70
Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventions
Gerges, S. H., Wahdan, S. A., Elsherbiny, D. A., & El‐Demerdash, E. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119220 · Cited by 76
Early Metabolic Adaptation in C57BL/6 Mice Resistant to High Fat Diet Induced Weight Gain Involves an Activation of Mitochondrial Oxidative Pathways
Boulangé, C. L., Claus, S. P., Chou, C. J., Collino, S., Montoliu, I., Kochhar, S., Holmes, E. C., Rezzi, S., Nicholson, J. K., Dumas, M., et al. (2013) · Journal of Proteome Research · doi:10.1021/pr400051s · Cited by 70
Steatohepatitis
Sterling, R. K., Contos, M. J., Smith, P. G., Stravitz, R. T., Luketic, V. A., Fuchs, M. A., Shiffman, M. L., & Sanyal, A. J. (2008) · Hepatology · doi:10.1002/hep.22134 · Cited by 69
Genetics Is of the Essence to Face NAFLD
Meroni, M., Longo, M., Tria, G., & Dongiovanni, P. (2021) · Biomedicines · doi:10.3390/biomedicines9101359 · Cited by 69
Experimental nonalcoholic steatohepatitis compromises ureagenesis, an essential hepatic metabolic function
Thomsen, K. L., Grønbæk, H., Glavind, E., Hebbard, L., Jessen, N., Clouston, A. D., George, J., & Vilstrup, H. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00036.2014 · Cited by 66
Curcumin ameliorates mitochondrial dysfunction associated with inhibition of gluconeogenesis in free fatty acid-mediated hepatic lipoapoptosis
KUO, J.-J., Chang, H., Tsai, T., & Lee, T.-Y. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1020 · Cited by 68
Attenuated progression of diet-induced steatohepatitis in glutathione-deficient mice
Haque, J. A., McMahan, R. S., Campbell, J. S., Shimizu‐Albergine, M., Wilson, A. M., Botta, D., Bammler, T. K., Beyer, R. P., Montine, T. J., Yeh, M. M., et al. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.112 · Cited by 66
ApoE deficiency promotes non-alcoholic fatty liver disease in mice via impeding AMPK/mTOR mediated autophagy
Lu, W., Mei, J., Yang, J., Wu, Z., Liu, J., Miao, P., Chen, Y., Wen, Z., Zhao, Z., Kong, H., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117601 · Cited by 65
Cyclophilin D deficiency attenuates mitochondrial perturbation and ameliorates hepatic steatosis
Wang, X., Du, H., Shao, S., Bo, T., Yu, C., Chen, W., Zhao, L., Li, Q., Wang, L., Liu, X., et al. (2018) · Hepatology · doi:10.1002/hep.29788 · Cited by 66
Methionine Deficiency and Hepatic Injury in a Dietary Steatohepatitis Model
Oz, H. S., Chen, T. S., & Neuman, M. G. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-9900-7 · Cited by 65
Prevention of free fatty acid‐induced hepatic lipotoxicity by carnitine via reversal of mitochondrial dysfunction
Jun, D. W., Cho, W. K., Jun, J. H., Kwon, H. J., Jang, K., Kim, H., Jeon, H. J., Lee, K. N., Lee, H. L., Lee, O. Y., et al. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02602.x · Cited by 64
Measurement of serum paraoxonase-1 activity in the evaluation of liver function
Camps, J., Marsillach, J., & Joven, J. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.1929 · Cited by 64
Targeting mitochondria to oppose the progression of nonalcoholic fatty liver disease
Grattagliano, I., Montezinho, L. P., Oliveira, P. J., Frühbeck, G., Gómez‐Ambrosi, J., Montecucco, F., Carbone, F., Wieckowski, M. R., Wang, D. Q. ‐., & Portincasa, P. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.11.020 · Cited by 66
Fatty Acid and Glucose Sensors in Hepatic Lipid Metabolism: Implications in NAFLD
Allison, M., Griffin, J. L., Vacca, M., & Vidal‐Puig, A. (2015) · Seminars in Liver Disease · doi:10.1055/s-0035-1562945 · Cited by 67
Liver Pyruvate Kinase Promotes NAFLD/NASH in Both Mice and Humans in a Sex-Specific Manner
Krishnan, K. C., Floyd, R. R., Sabir, S., Jayasekera, D. W., León‐Mimila, P., Jones, A. E., Cortez, A. A., Shravah, V., Péterfy, M., Stiles, L., et al. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.09.004 · Cited by 62
Aging‐induced aberrant RAGE/PPARα axis promotes hepatic steatosis via dysfunctional mitochondrial β oxidation
Wan, J., Wu, X., Chen, H., Xia, X., Song, X., Chen, S., Lu, X., Jin, J., Su, Q., Cai, D., et al. (2020) · Aging Cell · doi:10.1111/acel.13238 · Cited by 62
Remodeling of Mitochondrial Plasticity: The Key Switch from NAFLD/NASH to HCC
Longo, M., Paolini, E., Meroni, M., & Dongiovanni, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084173 · Cited by 61
Modulation of hepatic lipid metabolism by olive oil and its phenols in nonalcoholic fatty liver disease
Priore, P., Cavallo, A., Gnoni, A., Damiano, F., Gnoni, G. V., & Siculella, L. (2015) · IUBMB Life · doi:10.1002/iub.1340 · Cited by 61
Mulberry extract inhibits oleic acid‐induced lipid accumulation via reduction of lipogenesis and promotion of hepatic lipid clearance
Ou, T., Hsu, M., Chan, K., Huang, C., Ho, H.-H., & Wang, C. (2011) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.4489 · Cited by 61
Metabolic dysfunction and cancer in HCV: Shared pathways and mutual interactions
Leslie, J., Geh, D., Elsharkawy, A. M., Mann, D. A., & Vacca, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.01.029 · Cited by 61
Essential role of Nrf2 in the protective effect of lipoic acid against lipoapoptosis in hepatocytes
Valdecantos, M. P., Prieto-Hontoria, P. L., Pardo, V., Mòdol, T., Santamaría, B., Weber, M., Herrero, L., Serra, D., Muntané, J., Cuadrado, A., et al. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.03.019 · Cited by 58
Nonalcoholic Fatty Liver Disease: Clinical Features and Pathogenesis.
Başaranoğlu, M., & Neuschwander‐Tetri, B. A. (2006) · PubMed Central · Cited by 58
Decreased Circulating Endothelial Progenitor Cell Levels and Function in Patients with Nonalcoholic Fatty Liver Disease
Chiang, C.-H., Huang, P., Chung, F., Chen, Z.-Y., Leu, H., Huang, C., Wu, T.-C., Chen, J., & Lin, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031799 · Cited by 56
Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis
Schröder, T., Kucharczyk, D., Bär, F., Pagel, R., Derer, S., Jendrek, S. T., Sünderhauf, A., Brethack, A.-K., Hirose, M., Möller, S., et al. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.01.010 · Cited by 57
Alterations of hepatic energy metabolism in murine models of obesity, diabetes and fatty liver diseases
Dewidar, B., Mastrototaro, L., Englisch, C., Ress, C., Granata, C., Rohbeck, E., Pesta, D. H., Heilmann, G., Wolkersdorfer, M. F., Esposito, I., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104714 · Cited by 57
Gut microbial metabolites in MASLD: Implications of mitochondrial dysfunction in the pathogenesis and treatment
Zhang, R., Yan, Z., Zhong, H., Rong, L., Liu, W., Xiong, S., Liu, Q., & Liu, M. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000484 · Cited by 57
Diet-induced dyslipidemia leads to nonalcoholic fatty liver disease and oxidative stress in guinea pigs
Tveden‐Nyborg, P., Birck, M. M., Ipsen, D. H., Thiessen, T., Feldmann, L. D. B., Lindblad, M. M., Jensen, H. E., & Lykkesfeldt, J. (2015) · Translational research · doi:10.1016/j.trsl.2015.10.001 · Cited by 58
MiR-34a regulates mitochondrial content and fat ectopic deposition induced by resistin through the AMPK/PPARα pathway in HepG2 cells
Wen, F., An, C., Wu, X., Yang, Y., Xu, J., Liu, Y., Wang, C., Nie, L., Fang, H., & Yang, Z. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.11.008 · Cited by 57
Pediatric nonalcoholic fatty liver disease: Overview with emphasis on histology
Takahashi, Y. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i42.5280 · Cited by 55
Oxidative stress and steatosis are cofactors of liver injury in primary biliary cirrhosis
Sorrentino, P., Terracciano, L., D’Angelo, S., Ferbo, U., Bracigliano, A., Tarantino, L., Perrella, A., Perrella, O., Chiara, G. D., Panico, L., et al. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0249-x · Cited by 57
Mitochondrial ion transport pathways: Role in metabolic diseases
Cardoso, A. R., Queliconi, B. B., & Kowaltowski, A. J. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2009.12.017 · Cited by 54
Mitochondrial Targeting Therapeutics: Promising Role of Natural Products in Non-alcoholic Fatty Liver Disease
Xu, J., Shen, J., Yuan, R., Jia, B., Zhang, Y., Wang, S., Zhang, Y., Liu, M., & Wang, T. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.796207 · Cited by 53
Resistin reduces mitochondria and induces hepatic steatosis in mice by the protein kinase C/protein kinase G/p65/PPAR gamma coactivator 1 alpha pathway
Zhou, L., Yu, X., Meng, Q., Li, H., Niu, C., Jiang, Y., Cai, Y., Li, M., Li, Q., An, C., et al. (2012) · Hepatology · doi:10.1002/hep.26167 · Cited by 53
In utero exposure to benzo[a]pyrene increases adiposity and causes hepatic steatosis in female mice, and glutathione deficiency is protective
Ortiz, L., Nakamura, B. N., Li, X., Blumberg, B., & Luderer, U. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.09.017 · Cited by 54
Drug‐Induced Liver Injury
Pessayre, D., & Larrey, D. G. (2007) · Wiley eBooks · doi:10.1002/9780470691861.ch14a · Cited by 54
Self-citation
A common variant in the peroxisome proliferator–activated receptor-γ coactivator-1α gene is associated with nonalcoholic fatty liver disease in obese children
Lin, Y., Chang, P., Chang, M., & Ni, Y. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.046417 · Cited by 52
Impact of Glucoraphanin-Mediated Activation of Nrf2 on Non-Alcoholic Fatty Liver Disease with a Focus on Mitochondrial Dysfunction
Xu, L., Nagata, N., & Ota, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235920 · Cited by 51
Wnt/beta‐catenin signaling and its modulators in nonalcoholic fatty liver diseases
Harini, K. S., & Ezhilarasan, D. (2022) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2022.10.003 · Cited by 53
Comparison of dietary polyphenols for protection against molecular mechanisms underlying nonalcoholic fatty liver disease in a cell model of steatosis
Rafiei, H., Omidian, K., & Bandy, B. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600781 · Cited by 51
Identification of liver proteins altered by type 2 diabetes mellitus in obese subjects
Valle, A., Catalán, V., Rodrı́guez, A., Rotellar, F., Valentí, V., Silva, C., Salvador, J., Frühbeck, G., Gómez‐Ambrosi, J., Roca, P., et al. (2012) · Liver International · doi:10.1111/j.1478-3231.2012.02765.x · Cited by 49
Regulation of mitochondrial trifunctional protein modulates nonalcoholic fatty liver disease in mice
Nassir, F., Arndt, J. J., Johnson, S. A., & Ibdah, J. A. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m080952 · Cited by 49
Obstructive Sleep Apnea and the Liver
Parikh, M. P., Gupta, N. M., & McCullough, A. J. (2019) · Clinics in Liver Disease · doi:10.1016/j.cld.2019.01.001 · Cited by 49
MRG15 aggravates non-alcoholic steatohepatitis progression by regulating the mitochondrial proteolytic degradation of TUFM
Tian, C., Min, X., Zhao, Y., Wang, Y., Wu, X., Liu, S., Dou, W., Zhou, T., Liu, Y., Luo, R., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.07.017 · Cited by 49
Endothelial dysfunction in Turkish patients with non‐alcoholic fatty liver disease
Şentürk, Ö., Kocaman, O., Hülagü, S., Sahin, T., Aygün, C., Konduk, B. T., & Çelebi, A. (2007) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2007.01481.x · Cited by 47
Quercetin decreases liver damage in mice with non-alcoholic steatohepatitis.
Marcolin, É., Forgiarini, L. F., Rodrigues, G., Tieppo, J., Borghetti, G., Bassani, V., Picada, J., & Marroni, N. (2013) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12049 · Cited by 54
Retracted
Possible Involvement of Mitochondrial Dysfunction and Oxidative Stress in a Cellular Model of NAFLD Progression Induced by Benzo[a]pyrene/Ethanol CoExposure
Bucher, S., Guillou, D. L., Allard, J., Pinon, G., Begriche, K., Tête, A., Sergent, O., Lagadic‐Gossmann, D., & Fromenty, B. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/4396403 · Cited by 55
Self-citation
Mitochondrial adaptations to steatohepatitis induced by a methionine- and choline-deficient diet
Romestaing, C., Piquet, M., Letexier, D., Rey, B., Mourier, A., Servais, S., Belouze, M., Rouleau, V., Dautresme, M., Ollivier‐Hourmand, I., et al. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00407.2007 · Cited by 47
Reversal of hepatic steatosis by omega‐3 fatty acids measured non‐invasively by 1H‐magnetic resonance spectroscopy in a rat model
Marsman, H. A., Heger, M., Kloek, J. J., Nienhuis, S., van Werven, J. R., Nederveen, A. J., ten Kate, F. J. W., Stoker, J., & van Gulik, T. M. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06326.x · Cited by 46
Omega-3 fatty acids reduce hepatic steatosis and consequently attenuate ischemia-reperfusion injury following partial hepatectomy in rats
Marsman, H. A., Heger, M., Kloek, J. J., Nienhuis, S., ten Kate, F. J. W., & van Gulik, T. M. (2011) · Digestive and Liver Disease · doi:10.1016/j.dld.2011.07.009 · Cited by 45
Exercise as a therapeutic tool to prevent mitochondrial degeneration in nonalcoholic steatohepatitis
Gonçalves, I. O., Oliveira, P. J., Ascensão, A. A. M. R., & Magalhães, J. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12146 · Cited by 46
Renalase Attenuates Mouse Fatty Liver Ischemia/Reperfusion Injury through Mitigating Oxidative Stress and Mitochondrial Damage via Activating SIRT1
Zhang, T., Gu, J., Guo, J., Chen, K., Li, H., & Wang, J. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7534285 · Cited by 45
Retinol-Binding Protein 4 Induces Hepatic Mitochondrial Dysfunction and Promotes Hepatic Steatosis
Liu, Y., Mu, D., Chen, H., Li, D., Song, J., Yuan, Ž., & Xia, M. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1320 · Cited by 44
Mitochondrial Transfer by Human Mesenchymal Stromal Cells Ameliorates Hepatocyte Lipid Load in a Mouse Model of NASH
Hsu, M.-J., Karkossa, I., Schäfer, I., Christ, M., Kühne, H., Schubert, K., Rolle-Kampczyk, U. E., Kalkhof, S., Nickel, S., Seibel, P., et al. (2020) · Biomedicines · doi:10.3390/biomedicines8090350 · Cited by 43
Effect of valsartan on the pathological progression of hepatic fibrosis in rats with type 2 diabetes
Qiang, G., Zhang, L., Yang, X., Qi, X., Shi, L., Zhang, H., Chen, B., Li, X., Zu, M., Zhou, D., et al. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.04.028 · Cited by 43
13C‐breath tests for clinical investigation of liver mitochondrial function
Grattagliano, I., Lauterburg, B. H., Palasciano, G., & Portincasa, P. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02331.x · Cited by 42
Role of nonalcoholic fatty liver disease in the development of insulin resistance and diabetes
Grønbæk, H., Thomsen, K. L., Rungby, J., Schmitz, O., & Vilstrup, H. (2008) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2.5.705 · Cited by 44
Nonalcoholic fatty liver disease
Sotiropoulou, M. G., Katsaros, I., Vailas, M. G., Lidoriki, I., Papatheodoridis, G., Kostomitsopoulos, N. G., Valsami, G. N., Tsaroucha, A. K., & Schizas, D. (2021) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_249_21 · Cited by 43
Integrating the contributions of mitochondrial oxidative metabolism to lipotoxicity and inflammation in NAFLD pathogenesis
Hughey, C. C., Puchalska, P., & Crawford, P. A. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2022.159209 · Cited by 45
The proinflammatory phenotype of PECAM-1-deficient mice results in atherogenic diet-induced steatohepatitis
Goel, R., Boylan, B., Gruman, L. M., Newman, P. J., North, P. E., & Newman, D. K. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00157.2007 · Cited by 40
New concepts in the pathogenesis of alcoholic liver disease
Albano, E. (2008) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2.6.749 · Cited by 41
AGK regulates the progression to NASH by affecting mitochondria complex I function
Ding, N., Wang, K., Jiang, H., Yang, M., Zhang, L., Fan, X., Zou, Q., Yu, J., Dong, H., Cheng, S., et al. (2022) · Theranostics · doi:10.7150/thno.69826 · Cited by 40
Potential Therapeutic Implication of Herbal Medicine in Mitochondria-Mediated Oxidative Stress-Related Liver Diseases
Park, M. N., Rahman, M. A., Rahman, M. H., Kim, J. W., Choi, M. J., Kim, J. W., Choi, J., Moon, M., Ahmed, K. R., & Kim, B. (2022) · Antioxidants · doi:10.3390/antiox11102041 · Cited by 44
Mitochondrial function in liver cells is resistant to perturbations in NAD+ salvage capacity
Dall, M., Trammell, S. A. J., Asping, M., Hassing, A. S., Agerholm, M., Vienberg, S. G., Gillum, M. P., Larsen, S., & Treebak, J. T. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006756 · Cited by 40
Targeting Mitochondria as Therapeutic Strategy for Metabolic Disorders
Sorriento, D., Pascale, A. V., Finelli, R., Carillo, A. L., Annunziata, R., Trimarco, B., & Iaccarino, G. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/604685 · Cited by 39
Retracted
Treatment of patients with non-alcoholic fatty liver disease: Current views and perspectives
Federico, A., Trappoliere, M., & Loguercio, C. (2006) · Digestive and Liver Disease · doi:10.1016/j.dld.2006.04.009 · Cited by 38
Diminished stress resistance and defective adaptive homeostasis in age-related diseases
Lomeli, N., Bota, D. A., & Davies, K. J. A. (2017) · Clinical Science · doi:10.1042/cs20160982 · Cited by 39
HBx combined with AFB1 triggers hepatic steatosis via COX‐2‐mediated necrosome formation and mitochondrial dynamics disorder
Chen, Y., Lin, Y., Han, P., Jiang, S., Che, L., He, C., Lin, Y., & Lin, Z. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14388 · Cited by 38
Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
Miele, L., Forgione, A., Gasbarrini, A., & Grieco, A. (2007) · Translational research · doi:10.1016/j.trsl.2006.11.011 · Cited by 38
Treatment with geraniol ameliorates methionine‐choline‐deficient diet‐induced non‐alcoholic steatohepatitis in rats
Chen, J., Fan, X., Zhou, L., & Gao, X. (2015) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13272 · Cited by 37
The Nutraceutic Silybin Counteracts Excess Lipid Accumulation and Ongoing Oxidative Stress in an In Vitro Model of Non-Alcoholic Fatty Liver Disease Progression
Vecchione, G., Grasselli, E., Cioffi, F., Baldini, F., Oliveira, P. J., Sardão, V. A., Cortese, K., Lanni, A., Voci, A., Portincasa, P., et al. (2017) · Frontiers in Nutrition · doi:10.3389/fnut.2017.00042 · Cited by 37
Studying non-alcoholic fatty liver disease: the ins and outs of in vivo, ex vivo and in vitro human models
Green, C., Parry, S. A., Gunn, P. J., Ceresa, C. D. L., Rosqvist, F., Piché, M., & Hodson, L. (2018) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2018-0038 · Cited by 40

Authors: Pessayre, D., & Fromenty, B.
Affiliations: Inserm (FR)
Corresponding author: Pessayre, Dominique
ORCID: Fromenty, Bernard
Venue: Journal of Hepatology
Publisher: Elsevier BV
Published: 2005-06
Volume: 42
Issue: 6
Pages: 928-940
ISSN: 0168-8278 (ISSN-L)
DOI: 10.1016/j.jhep.2005.03.004
OpenAlex: W2022657181
Cited by: 441
References: 123
Citations by year: 2026: 9 · 2025: 14 · 2024: 17 · 2023: 19 · 2022: 27 · 2021: 33 · 2020: 25 · 2019: 20 · 2018: 29 · 2017: 21 · 2016: 11 · 2015: 19 · 2014: 26 · 2013: 20 · 2012: 19
FWCI: 14.65
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Journal of Hepatology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Keywords: nonalcoholic steatohepatitis, mitochondrial disease, obesity, mitochondrial dysfunction, fat deposition, energy expenditure
MeSH terms: Animals, Fatty Liver, Humans, Mitochondrial Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

NASH: a mitochondrial disease

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks